Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT04608604
Eligibility Criteria:
Inclusion Criteria:
* The subject is willing and able to give written informed consent
* The patient is able to tolerate all study visits including daily physiotherapy and home training.
* Patients similar with regard to age and sex with probable/possible MSA-P according to rev. Gilman criteria OR probable/possible PSP-RS according to MDS-PSP criteria OR PD according to MDS-PD criteria.
* Stable antiparkinsonian and Anti-OH medication 4 weeks prior to study entry.
Exclusion Criteria:
* Co-morbidities that influence the clinical presentation of parkinsonian symptoms (as judged by the enrolling investigator).
* Participation in other clinical trials that might influence the impact of the trial intervention (as judged by the enrolling investigator)
* H\&Y Staging score greater than or equal to 4
* Change of antiparkinsonian and anti-OH medication 4 weeks prior to the interventional trial.
* Secondary cause of autonomic failure or parkinsonism (e.g. diabetic autonomic neuropathy, bladder surgery, drug-induced or vascular parkinsonism, etc.)
* Dementia according to DSM-V.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT04608604
Study Brief:
Protocol Section:
NCT04608604